Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Enterprise Value (2020 - 2025)

Biofrontera (BFRI) has 6 years of Enterprise Value data on record, last reported at -$3.4 million in Q3 2025.

  • For Q3 2025, Enterprise Value fell 17.85% year-over-year to -$3.4 million; the TTM value through Sep 2025 reached -$3.4 million, down 17.85%, while the annual FY2024 figure was -$5.9 million, 316.05% down from the prior year.
  • Enterprise Value reached -$3.4 million in Q3 2025 per BFRI's latest filing, up from -$7.2 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$1.4 million in Q4 2023 and bottomed at -$31.9 million in Q2 2022.
  • Average Enterprise Value over 5 years is -$11.4 million, with a median of -$6.3 million recorded in 2023.
  • Peak YoY movement for Enterprise Value: plummeted 1502.56% in 2022, then soared 94.88% in 2023.
  • A 5-year view of Enterprise Value shows it stood at -$24.5 million in 2021, then fell by 13.29% to -$27.8 million in 2022, then skyrocketed by 94.88% to -$1.4 million in 2023, then tumbled by 316.05% to -$5.9 million in 2024, then surged by 42.03% to -$3.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Enterprise Value were -$3.4 million in Q3 2025, -$7.2 million in Q2 2025, and -$1.8 million in Q1 2025.